USE OF THE CONTINUOUS INSULIN INFUSION SYSTEM AND GLYCEMIC CONTROL IN CHILDREN, ADOLESCENTS AND YOUNG PEOPLE WITH TYPE 1 DIABETES MELLITUS

Abstract

Objective: To evaluate the impact of the use of the continuous insulin infusion system (SICI) on glycated hemoglobin (HbA1c) in children and young people with type 1 diabetes mellitus (DM)1. Method: The sample consisted of data from 402 consultations carried out from 2019 to 2023 at the Interdisciplinary Diabetes Center (CENID) of the University of Marília. Patients aged between 1 and 27 years were included in the study, 49.5% of whom were male and 50.5% female. Regarding the method of insulin administration, the patients were categorized into SICI and multiple doses of insulin (MDI). Glycemic control was assessed by HbA1c measurement and the values were categorized as adequate (<7%) and not adequate (≥ 7%). Results: In the sample, 30.3% used the SICI and 69.7% used the MDI. Between 2019 (27.8%) and 2023 (38.2%), an increase in the proportion of patients using SICI was observed. Regardless of the year, a significant association (p-value<0.001) was observed between SICI use and HbA1c values <7%. Among the patients using SICI, 32.8% had HbA1c <7%, while in the patients using MDI, only 14.6% had HbA1c values <7%. Conclusion: The use of SICI is an important tool in the treatment of DM1, as it contributes to the improvement of glycemic control assessed by HbA1c, and it is necessary to increase the number of patients using SICI in Brazil.